UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:MON2-BIRC6 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: MON2-BIRC6 | FusionPDB ID: 54567 | FusionGDB2.0 ID: 54567 | Hgene | Tgene | Gene symbol | MON2 | BIRC6 | Gene ID | 23041 | 57448 |
Gene name | MON2 homolog, regulator of endosome-to-Golgi trafficking | baculoviral IAP repeat containing 6 | |
Synonyms | - | APOLLON|BRUCE | |
Cytomap | 12q14.1 | 2p22.3 | |
Type of gene | protein-coding | protein-coding | |
Description | protein MON2 homologMON2 regulator of endosome-to-Golgi trafficking | baculoviral IAP repeat-containing protein 6BIR repeat-containing ubiquitin-conjugating enzymeRING-type E3 ubiquitin transferase BIRC6ubiquitin-conjugating BIR-domain enzyme apollon | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q7Z3U7 | Q9NR09 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000280379, ENST00000393629, ENST00000393630, ENST00000393632, ENST00000546600, ENST00000552115, ENST00000552738, ENST00000549378, ENST00000551397, | ENST00000421745, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 18 X 13 X 7=1638 | 23 X 19 X 14=6118 |
# samples | 19 | 29 | |
** MAII score | log2(19/1638*10)=-3.10786403331006 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(29/6118*10)=-4.39893530154327 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: MON2 [Title/Abstract] AND BIRC6 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | MON2(62878013)-BIRC6(32800223), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | MON2-BIRC6 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. MON2-BIRC6 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. MON2-BIRC6 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. MON2-BIRC6 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-D7-5577-01A | MON2 | chr12 | 62878013 | + | BIRC6 | chr2 | 32800223 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000280379 | MON2 | chr12 | 62878013 | + | ENST00000421745 | BIRC6 | chr2 | 32800223 | + | 2991 | 566 | 349 | 1995 | 548 |
ENST00000393632 | MON2 | chr12 | 62878013 | + | ENST00000421745 | BIRC6 | chr2 | 32800223 | + | 2991 | 566 | 349 | 1995 | 548 |
ENST00000393630 | MON2 | chr12 | 62878013 | + | ENST00000421745 | BIRC6 | chr2 | 32800223 | + | 2991 | 566 | 349 | 1995 | 548 |
ENST00000546600 | MON2 | chr12 | 62878013 | + | ENST00000421745 | BIRC6 | chr2 | 32800223 | + | 2986 | 561 | 344 | 1990 | 548 |
ENST00000552738 | MON2 | chr12 | 62878013 | + | ENST00000421745 | BIRC6 | chr2 | 32800223 | + | 2960 | 535 | 318 | 1964 | 548 |
ENST00000393629 | MON2 | chr12 | 62878013 | + | ENST00000421745 | BIRC6 | chr2 | 32800223 | + | 2960 | 535 | 318 | 1964 | 548 |
ENST00000552115 | MON2 | chr12 | 62878013 | + | ENST00000421745 | BIRC6 | chr2 | 32800223 | + | 2959 | 534 | 317 | 1963 | 548 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000280379 | ENST00000421745 | MON2 | chr12 | 62878013 | + | BIRC6 | chr2 | 32800223 | + | 0.000748785 | 0.9992512 |
ENST00000393632 | ENST00000421745 | MON2 | chr12 | 62878013 | + | BIRC6 | chr2 | 32800223 | + | 0.000748785 | 0.9992512 |
ENST00000393630 | ENST00000421745 | MON2 | chr12 | 62878013 | + | BIRC6 | chr2 | 32800223 | + | 0.000748785 | 0.9992512 |
ENST00000546600 | ENST00000421745 | MON2 | chr12 | 62878013 | + | BIRC6 | chr2 | 32800223 | + | 0.000765791 | 0.9992342 |
ENST00000552738 | ENST00000421745 | MON2 | chr12 | 62878013 | + | BIRC6 | chr2 | 32800223 | + | 0.000719581 | 0.9992804 |
ENST00000393629 | ENST00000421745 | MON2 | chr12 | 62878013 | + | BIRC6 | chr2 | 32800223 | + | 0.000719581 | 0.9992804 |
ENST00000552115 | ENST00000421745 | MON2 | chr12 | 62878013 | + | BIRC6 | chr2 | 32800223 | + | 0.000717713 | 0.9992823 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >54567_54567_1_MON2-BIRC6_MON2_chr12_62878013_ENST00000280379_BIRC6_chr2_32800223_ENST00000421745_length(amino acids)=548AA_BP=70 MFVPLGNWLGPWRIMSGTSSPEAVKKLLENMQSDLRALSLECKKKFPPVKEAAESGIIKVKTIAARNTEILAVLDMARHVPLYRALLELL RAIASCAAMVPLLLPLSTENGEEEEEQSECQTSVGTLLAKMKTCVDTYTNRLRSKRENVKTGVKPDASDQEPEGLTLLVPDIQKTAEIVY AATTSLRQANQEKKLGEYSKKAAMKPKPLSVLKSLEEKYVAVMKKLQFDTFEMVSEDEDGKLGFKVNYHYMSQVKNANDANSAARARRLA QEAVTLSTSLPLSSSSSVFVRCDEERLDIMKVLITGPADTPYANGCFEFDVYFPQDYPSSPPLVNLETTGGHSVRFNPNLYNDGKVCLSI LNTWHGRPEEKWNPQTSSFLQVLVSVQSLILVAEPYFNEPGYERSRGTPSGTQSSREYDGNIRQATVKWAMLEQIRNPSPCFKEVIHKHF YLKRVEIMAQCEEWIADIQQYSSDKRVGRTMSHHAAALKRHTAQLREELLKLPCPEGLDPDTDDAPEVCRATTGAEETLMHDQVKPSSSK -------------------------------------------------------------- >54567_54567_2_MON2-BIRC6_MON2_chr12_62878013_ENST00000393629_BIRC6_chr2_32800223_ENST00000421745_length(amino acids)=548AA_BP=70 MFVPLGNWLGPWRIMSGTSSPEAVKKLLENMQSDLRALSLECKKKFPPVKEAAESGIIKVKTIAARNTEILAVLDMARHVPLYRALLELL RAIASCAAMVPLLLPLSTENGEEEEEQSECQTSVGTLLAKMKTCVDTYTNRLRSKRENVKTGVKPDASDQEPEGLTLLVPDIQKTAEIVY AATTSLRQANQEKKLGEYSKKAAMKPKPLSVLKSLEEKYVAVMKKLQFDTFEMVSEDEDGKLGFKVNYHYMSQVKNANDANSAARARRLA QEAVTLSTSLPLSSSSSVFVRCDEERLDIMKVLITGPADTPYANGCFEFDVYFPQDYPSSPPLVNLETTGGHSVRFNPNLYNDGKVCLSI LNTWHGRPEEKWNPQTSSFLQVLVSVQSLILVAEPYFNEPGYERSRGTPSGTQSSREYDGNIRQATVKWAMLEQIRNPSPCFKEVIHKHF YLKRVEIMAQCEEWIADIQQYSSDKRVGRTMSHHAAALKRHTAQLREELLKLPCPEGLDPDTDDAPEVCRATTGAEETLMHDQVKPSSSK -------------------------------------------------------------- >54567_54567_3_MON2-BIRC6_MON2_chr12_62878013_ENST00000393630_BIRC6_chr2_32800223_ENST00000421745_length(amino acids)=548AA_BP=70 MFVPLGNWLGPWRIMSGTSSPEAVKKLLENMQSDLRALSLECKKKFPPVKEAAESGIIKVKTIAARNTEILAVLDMARHVPLYRALLELL RAIASCAAMVPLLLPLSTENGEEEEEQSECQTSVGTLLAKMKTCVDTYTNRLRSKRENVKTGVKPDASDQEPEGLTLLVPDIQKTAEIVY AATTSLRQANQEKKLGEYSKKAAMKPKPLSVLKSLEEKYVAVMKKLQFDTFEMVSEDEDGKLGFKVNYHYMSQVKNANDANSAARARRLA QEAVTLSTSLPLSSSSSVFVRCDEERLDIMKVLITGPADTPYANGCFEFDVYFPQDYPSSPPLVNLETTGGHSVRFNPNLYNDGKVCLSI LNTWHGRPEEKWNPQTSSFLQVLVSVQSLILVAEPYFNEPGYERSRGTPSGTQSSREYDGNIRQATVKWAMLEQIRNPSPCFKEVIHKHF YLKRVEIMAQCEEWIADIQQYSSDKRVGRTMSHHAAALKRHTAQLREELLKLPCPEGLDPDTDDAPEVCRATTGAEETLMHDQVKPSSSK -------------------------------------------------------------- >54567_54567_4_MON2-BIRC6_MON2_chr12_62878013_ENST00000393632_BIRC6_chr2_32800223_ENST00000421745_length(amino acids)=548AA_BP=70 MFVPLGNWLGPWRIMSGTSSPEAVKKLLENMQSDLRALSLECKKKFPPVKEAAESGIIKVKTIAARNTEILAVLDMARHVPLYRALLELL RAIASCAAMVPLLLPLSTENGEEEEEQSECQTSVGTLLAKMKTCVDTYTNRLRSKRENVKTGVKPDASDQEPEGLTLLVPDIQKTAEIVY AATTSLRQANQEKKLGEYSKKAAMKPKPLSVLKSLEEKYVAVMKKLQFDTFEMVSEDEDGKLGFKVNYHYMSQVKNANDANSAARARRLA QEAVTLSTSLPLSSSSSVFVRCDEERLDIMKVLITGPADTPYANGCFEFDVYFPQDYPSSPPLVNLETTGGHSVRFNPNLYNDGKVCLSI LNTWHGRPEEKWNPQTSSFLQVLVSVQSLILVAEPYFNEPGYERSRGTPSGTQSSREYDGNIRQATVKWAMLEQIRNPSPCFKEVIHKHF YLKRVEIMAQCEEWIADIQQYSSDKRVGRTMSHHAAALKRHTAQLREELLKLPCPEGLDPDTDDAPEVCRATTGAEETLMHDQVKPSSSK -------------------------------------------------------------- >54567_54567_5_MON2-BIRC6_MON2_chr12_62878013_ENST00000546600_BIRC6_chr2_32800223_ENST00000421745_length(amino acids)=548AA_BP=70 MFVPLGNWLGPWRIMSGTSSPEAVKKLLENMQSDLRALSLECKKKFPPVKEAAESGIIKVKTIAARNTEILAVLDMARHVPLYRALLELL RAIASCAAMVPLLLPLSTENGEEEEEQSECQTSVGTLLAKMKTCVDTYTNRLRSKRENVKTGVKPDASDQEPEGLTLLVPDIQKTAEIVY AATTSLRQANQEKKLGEYSKKAAMKPKPLSVLKSLEEKYVAVMKKLQFDTFEMVSEDEDGKLGFKVNYHYMSQVKNANDANSAARARRLA QEAVTLSTSLPLSSSSSVFVRCDEERLDIMKVLITGPADTPYANGCFEFDVYFPQDYPSSPPLVNLETTGGHSVRFNPNLYNDGKVCLSI LNTWHGRPEEKWNPQTSSFLQVLVSVQSLILVAEPYFNEPGYERSRGTPSGTQSSREYDGNIRQATVKWAMLEQIRNPSPCFKEVIHKHF YLKRVEIMAQCEEWIADIQQYSSDKRVGRTMSHHAAALKRHTAQLREELLKLPCPEGLDPDTDDAPEVCRATTGAEETLMHDQVKPSSSK -------------------------------------------------------------- >54567_54567_6_MON2-BIRC6_MON2_chr12_62878013_ENST00000552115_BIRC6_chr2_32800223_ENST00000421745_length(amino acids)=548AA_BP=70 MFVPLGNWLGPWRIMSGTSSPEAVKKLLENMQSDLRALSLECKKKFPPVKEAAESGIIKVKTIAARNTEILAVLDMARHVPLYRALLELL RAIASCAAMVPLLLPLSTENGEEEEEQSECQTSVGTLLAKMKTCVDTYTNRLRSKRENVKTGVKPDASDQEPEGLTLLVPDIQKTAEIVY AATTSLRQANQEKKLGEYSKKAAMKPKPLSVLKSLEEKYVAVMKKLQFDTFEMVSEDEDGKLGFKVNYHYMSQVKNANDANSAARARRLA QEAVTLSTSLPLSSSSSVFVRCDEERLDIMKVLITGPADTPYANGCFEFDVYFPQDYPSSPPLVNLETTGGHSVRFNPNLYNDGKVCLSI LNTWHGRPEEKWNPQTSSFLQVLVSVQSLILVAEPYFNEPGYERSRGTPSGTQSSREYDGNIRQATVKWAMLEQIRNPSPCFKEVIHKHF YLKRVEIMAQCEEWIADIQQYSSDKRVGRTMSHHAAALKRHTAQLREELLKLPCPEGLDPDTDDAPEVCRATTGAEETLMHDQVKPSSSK -------------------------------------------------------------- >54567_54567_7_MON2-BIRC6_MON2_chr12_62878013_ENST00000552738_BIRC6_chr2_32800223_ENST00000421745_length(amino acids)=548AA_BP=70 MFVPLGNWLGPWRIMSGTSSPEAVKKLLENMQSDLRALSLECKKKFPPVKEAAESGIIKVKTIAARNTEILAVLDMARHVPLYRALLELL RAIASCAAMVPLLLPLSTENGEEEEEQSECQTSVGTLLAKMKTCVDTYTNRLRSKRENVKTGVKPDASDQEPEGLTLLVPDIQKTAEIVY AATTSLRQANQEKKLGEYSKKAAMKPKPLSVLKSLEEKYVAVMKKLQFDTFEMVSEDEDGKLGFKVNYHYMSQVKNANDANSAARARRLA QEAVTLSTSLPLSSSSSVFVRCDEERLDIMKVLITGPADTPYANGCFEFDVYFPQDYPSSPPLVNLETTGGHSVRFNPNLYNDGKVCLSI LNTWHGRPEEKWNPQTSSFLQVLVSVQSLILVAEPYFNEPGYERSRGTPSGTQSSREYDGNIRQATVKWAMLEQIRNPSPCFKEVIHKHF YLKRVEIMAQCEEWIADIQQYSSDKRVGRTMSHHAAALKRHTAQLREELLKLPCPEGLDPDTDDAPEVCRATTGAEETLMHDQVKPSSSK -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:62878013/chr2:32800223) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
MON2 | BIRC6 |
FUNCTION: Plays a role in regulating membrane trafficking of cargo proteins. Together with ATP9A and DOP1B, regulates SNX3 retromer-mediated endosomal sorting of WLS away from lysosomal degradation. {ECO:0000269|PubMed:30213940}. | FUNCTION: Anti-apoptotic protein which can regulate cell death by controlling caspases and by acting as an E3 ubiquitin-protein ligase. Has an unusual ubiquitin conjugation system in that it could combine in a single polypeptide, ubiquitin conjugating (E2) with ubiquitin ligase (E3) activity, forming a chimeric E2/E3 ubiquitin ligase. Its tragets include CASP9 and DIABLO/SMAC. Acts as an inhibitor of CASP3, CASP7 and CASP9. Important regulator for the final stages of cytokinesis. Crucial for normal vesicle targeting to the site of abscission, but also for the integrity of the midbody and the midbody ring, and its striking ubiquitin modification. {ECO:0000269|PubMed:14765125, ECO:0000269|PubMed:15200957, ECO:0000269|PubMed:18329369}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | BIRC6 | chr12:62878013 | chr2:32800223 | ENST00000421745 | 64 | 74 | 4573_4740 | 4381.333333333333 | 4858.0 | Domain | UBC core |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | BIRC6 | chr12:62878013 | chr2:32800223 | ENST00000421745 | 64 | 74 | 1660_1668 | 4381.333333333333 | 4858.0 | Compositional bias | Note=Poly-Ala | |
Tgene | BIRC6 | chr12:62878013 | chr2:32800223 | ENST00000421745 | 64 | 74 | 30_36 | 4381.333333333333 | 4858.0 | Compositional bias | Note=Poly-Ala | |
Tgene | BIRC6 | chr12:62878013 | chr2:32800223 | ENST00000421745 | 64 | 74 | 284_358 | 4381.333333333333 | 4858.0 | Repeat | Note=BIR |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
MON2 | |
BIRC6 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to MON2-BIRC6 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to MON2-BIRC6 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |